Pfizer

Page 26 of 37

Resurgent airlines, energy and bank stocks lead the way as the vaccine rally intensifies
Newsletters

Resurgent airlines, energy and bank stocks lead the way as the vaccine rally intensifies

By
November 24, 2020
Stocks and futures jump on AstraZeneca’s vaccine breakthrough. Here are the big winners
Newsletters

Stocks and futures jump on AstraZeneca’s vaccine breakthrough. Here are the big winners

By
November 23, 2020
AstraZeneca says its Covid-19 vaccine is up to 90% effective
Health

AstraZeneca says its Covid-19 vaccine is up to 90% effective

By
November 23, 2020
The great disconnect: Big cash is surging into the markets, and yet COVID is socking stocks
Newsletters

The great disconnect: Big cash is surging into the markets, and yet COVID is socking stocks

By
November 20, 2020
The vaccine rally is on pause, even slowing Bitcoin’s march
Newsletters

The vaccine rally is on pause, even slowing Bitcoin’s march

By
November 19, 2020
Pfizer, BioNTech plan filing as COVID trials show their vaccine is 95% effective
Health

Pfizer, BioNTech plan filing as COVID trials show their vaccine is 95% effective

By Robert Langreth and Bloomberg
November 18, 2020
Here are the most bullish trades for 2021—and, no, Bitcoin does not top the list
Newsletters

Here are the most bullish trades for 2021—and, no, Bitcoin does not top the list

By
November 18, 2020
Empty seats are seen in terminal 1 at the "Berlin Brandenburg Airport Willy Brandt" in Schoenefeld, south-east of Berlin, on November 6, 2020. - British lowcost airline Easyjet announced on November 6, 2020, that it was reducing its flight capacity for the first quarter of 2021 to "at most 20%" of what it initially planned for this period, in reaction to the containment measures announced across Europe to combat the Covid-19 pandemic/

Airlines saw an immediate boost in passenger bookings following vaccine announcements

By
November 17, 2020
Warren Buffett is going all in on the vaccine rally, piling into these stocks
Finance

Warren Buffett is going all in on the vaccine rally, piling into these stocks

By Katherine Chiglinsky and Bloomberg
November 17, 2020
Vaccine breakthroughs are unleashing a ‘value rally.’ Here’s what investors should know
Newsletters

Vaccine breakthroughs are unleashing a ‘value rally.’ Here’s what investors should know

By
November 17, 2020
Moderna says its COVID-19 vaccine is 94.5% effective
Health

Moderna says its COVID-19 vaccine is 94.5% effective

By Robert Langreth and Bloomberg
November 16, 2020
Moderna shares soar as markets bet its COVID vaccine trial is on the same track as Pfizer’s
Health

Moderna shares soar as markets bet its COVID vaccine trial is on the same track as Pfizer’s

By Robert Langreth and Bloomberg
November 12, 2020
The vaccine jolt fades, sinking global stocks—except for this one surprising sector
Newsletters

The vaccine jolt fades, sinking global stocks—except for this one surprising sector

By
November 12, 2020
Cold storage requirements will create a vast logistical nightmare for distributing COVID-19 vaccine
Health

Cold storage requirements will create a vast logistical nightmare for distributing COVID-19 vaccine

By
November 11, 2020
Eli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA
Health

Eli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA

By Riley Griffin and Bloomberg
November 10, 2020

Most Popular